U.K. GUNITE LIMITED

Financial Health Assessment: U.K. GUNITE LIMITED

1. Financial Health Score: D+

Explanation: While the patient possesses a strong skeletal structure (high net assets), it is currently suffering from severe financial anemia. The company has virtually no cash reserves to sustain daily operations, relying heavily on a massive debt owed by its own director. This creates a precarious position where the business is theoretically solvent but practically illiquid. The drastic reduction in workforce also suggests a contraction in operational capacity.

2. Key Vital Signs

Blood Pressure (Liquidity Ratio) * Reading: Current Assets (£7.02m) vs. Current Liabilities (£2.72m) = 2.58:1 * Interpretation: On the surface, the blood pressure appears healthy. For every pound owed short-term, the company has £2.58 in short-term assets. However, this reading is dangerously misleading because the "blood" is not flowing—it is trapped (see Cholesterol below).

Pulse (Cash Position) * Reading: £7 (Down from £481,237 in 2021) * Interpretation: The patient's pulse is barely perceptible. A cash balance of £7 in a company with £7m in assets indicates a complete failure in cash flow management. The company has no immediate liquidity to handle emergencies, pay suppliers promptly, or take advantage of opportunities.

Cholesterol (Director's Loan) * Reading: £3,792,902 owed by the director * Interpretation: This is the critical blockage. Over 54% of the company’s total assets and 57% of its debtors consist of a loan extracted by the director. This money is not circulating in the business (paying bills or generating returns) but is sitting in the director's personal accounts. This "internal bleeding" is the root cause of the cash starvation.

Weight (Net Assets) * Reading: £4,440,881 (Up from £3,604,100 in 2025) * Interpretation: The patient is heavy. Net assets have grown, suggesting retained profitability, but the composition of this weight is unhealthy. It is comprised mostly of the director's debt rather than productive assets or cash.

Heartbeat (Workforce) * Reading: 9 employees (Down from 16 in 2025) * Interpretation: The heart muscle has weakened. A 44% drop in headcount suggests a significant contraction in operations, which may impact future revenue capacity.

3. Diagnosis

Severe Liquidity Anemia with Complications from Director Extraction

The financial data reveals a company that is "asset rich but cash poor." The business appears profitable on paper (evidenced by growing retained profits in the P&L reserve), but this profitability has been siphoned off. The primary symptom is the Director's Loan Account (DLA) of nearly £3.8 million.

• The Paradox: The company owes £1.24 million in Corporation Tax, but only has £7 in the bank. It can only pay this tax if the director repays the loan. If the director defaults or delays repayment, the company faces a "cardiac arrest"—an inability to meet its fiscal obligations despite being technically solvent.
• Risk of Infection: With such low cash reserves, the company is highly vulnerable to payment delays from clients or unexpected costs. The reduction in staff numbers (from 16 to 9) may be a cost-saving measure, but it risks reducing the company's ability to generate the revenue needed to recover.

4. Recommendations

To restore financial wellness, the following intensive care measures are required:

1. Arterial Clearing (Director Loan Repayment): This is the priority. The director must establish a formal, strict repayment schedule for the £3.8 million loan. Given the severity of the cash position, significant repayments should be made immediately to clear the outstanding Corporation Tax liability and rebuild working capital.
2. Blood Transfusion (Cash Injection): If the director cannot repay the loan immediately, alternative funding must be secured. The company has £604k in bank loans/overdrafts; it may need to restructure debt or seek external investment to ensure cash flow remains positive.
3. Dietary Control (Cash Flow Management): Implement stricter credit control. While trade debtors are relatively low (£167k), ensuring prompt collection is vital when cash reserves are £7.
4. Health Monitoring (Governance): The fact that the director owes the company nearly £3.8 million raises significant governance concerns. The shareholders (including Ms. Eloise Jones and Mrs. Tia Johnson, who hold significant control) must exert pressure to ensure this loan is repaid or converted into equity if it was effectively a dividend, to ensure transparency and fairness.